These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4883798)

  • 1. [Hematopoietic system in cyanotic congenital heart disease].
    Lewandowska K; Rachocka J
    Pol Tyg Lek; 1968 Dec; 23(51):1984-6. PubMed ID: 4883798
    [No Abstract]   [Full Text] [Related]  

  • 2. [The hematopoietic system in patients with congenital cyanotic heart disease].
    Pellar J
    Wiad Lek; 1968 Oct; 21(20):1811-4. PubMed ID: 4883228
    [No Abstract]   [Full Text] [Related]  

  • 3. Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases.
    Osthaus WA; Boethig D; Johanning K; Rahe-Meyer N; Theilmeier G; Breymann T; Suempelmann R
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):220-5. PubMed ID: 18388502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyanotic congenital heart disease in children: hemostatic disorders and relevance of molecular markers of hemostasis.
    Suarez CR; Menendez CE; Griffin AJ; Ow EP; Walenga JM; Fareed J
    Semin Thromb Hemost; 1984 Oct; 10(4):285-9. PubMed ID: 6515422
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of coagulation factors in cyanotic children with congenital heart defects].
    Goldschmidt B
    Ann Paediatr; 1966; 207(5):321-8. PubMed ID: 6012677
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional hyposplenia in cyanotic congenital heart disease.
    Pearson HA; Schiebler GL; Spencer RP
    Pediatrics; 1971 Aug; 48(2):277-80. PubMed ID: 5560621
    [No Abstract]   [Full Text] [Related]  

  • 7. Haematological considerations in patients with cyanotic congenital heart disease: a review.
    Auluck A; Manohar C
    Dent Update; 2006 Dec; 33(10):617-8, 620-2. PubMed ID: 17209537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic defect in cyanotic and acyanotic congenital heart disease.
    Jootar S; Archararit N; Suvachittanont O
    J Med Assoc Thai; 1988 Jul; 71(7):382-7. PubMed ID: 3241136
    [No Abstract]   [Full Text] [Related]  

  • 9. Hematologic disorders and congenital cardiovascular malformations: converging lines of research.
    Ferencz C; Rubin JD; McCarter RJ; Wilson PD; Boughman JA; Brenner JI; Neill CA; Perry LW; Hepner SI; Downing JW
    J Med; 1984; 15(5-6):337-54. PubMed ID: 6399520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiologic consequences of cyanotic congenital heart disease.
    Rao PS
    Indian J Pediatr; 1983; 50(406):479-87. PubMed ID: 6674196
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic widespread intravascular coagulation syndrome and cyanotic congenital cardiopathy. The place of heparin during preoperative period].
    Baille Y; Blanc T; Monties JR; Goudard A; Henry E
    Presse Med (1893); 1970 Aug; 78(36):1571-4. PubMed ID: 5456287
    [No Abstract]   [Full Text] [Related]  

  • 12. [Incidence of anaemia in congenital heart diseases (author's transl)].
    Drossos C; Thanapoulos B; Papadimitrou T; Milingos M; Papadimitrou A; Kostantelloy E; Ikkos D
    Pediatr Med Chir; 1981; 3(4):309-12. PubMed ID: 7343922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Care of the adult with cyanotic congenital heart disease.
    Miner PD; Canobbio MM
    Nurs Clin North Am; 1994 Jun; 29(2):249-67. PubMed ID: 7515491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abnormalities of hemostasis in congenital heart diseases].
    Chipail A; Schneer JH
    Pediatria (Bucur); 1970; 19(5):439-42. PubMed ID: 5491732
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of vitamin K on clotting factors in children with congenital cyanotic heart disease.
    Goldschmidt B
    Acta Paediatr Acad Sci Hung; 1970; 11(2):135-9. PubMed ID: 5504583
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum vascular endothelial growth factor in cyanotic congenital heart disease functionally contributes to endothelial cell kinetics in vitro.
    Hamada H; Ebata R; Higashi K; Tateno S; Niwa K; Honda T; Yasukawa K; Terai M
    Int J Cardiol; 2007 Aug; 120(1):66-71. PubMed ID: 17126928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanotic congenital heart disease (CCHD): focus on hypoxemia, secondary erythrocytosis, and coagulation alterations.
    Zabala LM; Guzzetta NA
    Paediatr Anaesth; 2015 Oct; 25(10):981-9. PubMed ID: 26184479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation abnormalities in patients with cyanotic congenital heart disease.
    Tempe DK; Virmani S
    J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):752-65. PubMed ID: 12486661
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyanotic heart disease and psychological development.
    Silbert A; Wolff PH; Mayer B; Rosenthal A; Nadas AS
    Pediatrics; 1969 Feb; 43(2):192-200. PubMed ID: 5763857
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction to the physiology of congenital heart disease with cyanosis.
    Verheugt AP
    Radiol Clin Biol; 1970; 39(2):67-74. PubMed ID: 5426157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.